Carbosol 450 mg Injection (Carboplatin) — Platinum-Based Chemotherapy for Solid Tumours Carbosol 450 mg Injection contains carboplatin, a platinum-based chemotherapy medicine widely used in the treatment of various solid tumours, including ovarian, lung, head & neck, endometrial, and testicular cancers. It works by binding to the DNA of cancer cells, disrupting their ability to replicate, which leads to cancer cell death. Administered as an intravenous infusion in hospitals or cancer clinics under strict oncological supervision, carboplatin is often part of combination chemotherapy regimens to enhance effectiveness and improve outcomes. Due to its potent effects and possible side effects — such as bone marrow suppression, nausea, kidney function changes, and hearing effects — careful medical monitoring including blood counts and kidney tests is essential throughout treatment.